131 related articles for article (PubMed ID: 7935664)
1. Insulin resistance and the prevention of diabetes mellitus.
Keen H
N Engl J Med; 1994 Nov; 331(18):1226-7. PubMed ID: 7935664
[No Abstract] [Full Text] [Related]
2. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
3. Targeted glycemic control in type 2 diabetes.
Skyler JS
J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
[No Abstract] [Full Text] [Related]
4. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
[TBL] [Abstract][Full Text] [Related]
5. New directions in treating insulin resistance.
Reusch JE
Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
[No Abstract] [Full Text] [Related]
6. New diabetes drug targets insulin resistance.
Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
[No Abstract] [Full Text] [Related]
7. The role of troglitazone in treating the insulin resistance syndrome.
Granberry MC; Schneider EF; Fonseca VA
Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
[TBL] [Abstract][Full Text] [Related]
8. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
9. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
10. Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
Yoshioka K; Yokoo S; Yoshida T; Kondo M
Diabetes Care; 1997 Aug; 20(8):1340-1. PubMed ID: 9250469
[No Abstract] [Full Text] [Related]
11. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
12. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
13. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
14. Warner Lambert/Sankyo diabetes drug nears market.
Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
[No Abstract] [Full Text] [Related]
15. Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.
Zimmet P; Collier G
Drugs; 1999; 58 Suppl 1():21-8; discussion 75-82. PubMed ID: 10576521
[TBL] [Abstract][Full Text] [Related]
16. [Causal therapy of type 2 diabetes. Determining the cause of insulin resistance early].
MMW Fortschr Med; 2000 Nov; 142(47):56. PubMed ID: 11143782
[No Abstract] [Full Text] [Related]
17. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and beta-cell function--a clinical perspective.
Matthews DR
Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
[No Abstract] [Full Text] [Related]
19. Lipoatrophy, lipodystrophy, and insulin resistance.
Ganda OP
Ann Intern Med; 2000 Aug; 133(4):304-6. PubMed ID: 10929174
[No Abstract] [Full Text] [Related]
20. Potential role of thiazolidinediones in older diabetic patients.
Umeda F
Drugs Aging; 1995 Nov; 7(5):331-7. PubMed ID: 8573988
[No Abstract] [Full Text] [Related]
[Next] [New Search]